Clinical Trial Update: Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing vaccination responses in multiple sclerosis patients treated with Tecfidera (dimethyl fumarate) versus interferon therapy; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)
• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Relapsing Forms of Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02